Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model

被引:236
作者
He, XP
Kotloski, R
Nef, S
Luikart, BW
Parada, LF
McNamara, JO [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA
[4] Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA
[5] Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA
关键词
D O I
10.1016/j.neuron.2004.06.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epileptogenesis is the process whereby a normal brain becomes epileptic. We hypothesized that the neurotrophin brain-derived neurotrophic factor (BDNF) activates its receptor, TrkB, in the hippocampus during epileptogenesis and that BDNF-mediated activation of TrkB is required for epileptogenesis. We tested these hypotheses in Synapsin-Cre conditional BDNF-/- and TrkB(-/-) mice using the kindling model. Despite marked reductions of BDNF expression, only a modest impairment of epileptogenesis and increased hippocampal TrkB activation were detected in BDNF-/- mice. In contrast, reductions of electrophysiological measures and no behavioral evidence of epileptogenesis were detected in TrkB(-/-) mice. Importantly, TrkB(-/-) mice exhibited behavioral endpoints of epileptogenesis, tonic-clonic seizures. Whereas TrkB can be activated, and epileptogenesis develops in BDNF-/- mice, the plasticity of epileptogenesis is eliminated in TrkB(-/-) mice. Its requirement for epileptogenesis in kindling implicates TrkB and downstream signaling pathways as attractive molecular targets for drugs for preventing epilepsy.
引用
收藏
页码:31 / 42
页数:12
相关论文
共 53 条
[21]   SUPPRESSED EPILEPTOGENESIS IN BDNF MUTANT MICE [J].
KOKAIA, M ;
ERNFORS, P ;
KOKAIA, Z ;
ELMER, E ;
JAENISCH, R ;
LINDVALL, O .
EXPERIMENTAL NEUROLOGY, 1995, 133 (02) :215-224
[22]   A role for BDNF in the late-phase of hippocampal long-term potentiation [J].
Korte, M ;
Kang, H ;
Bonhoeffer, T ;
Schuman, E .
NEUROPHARMACOLOGY, 1998, 37 (4-5) :553-559
[23]  
KRAUS JE, 1994, J NEUROSCI, V14, P4196
[24]   Activation of Trk neurotrophin receptors in the absence of neurotrophins [J].
Lee, FS ;
Chao, MV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3555-3560
[25]  
Löscher W, 1998, J PHARMACOL EXP THER, V284, P474
[26]   Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs.: A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy [J].
Löscher, W .
EPILEPSY RESEARCH, 2002, 50 (1-2) :105-123
[27]   NEUROTROPHIN-3 - A NEUROTROPHIC FACTOR RELATED TO NGF AND BDNF [J].
MAISONPIERRE, PC ;
BELLUSCIO, L ;
SQUINTO, S ;
IP, NY ;
FURTH, ME ;
LINDSAY, RM ;
YANCOPOULOS, GD .
SCIENCE, 1990, 247 (4949) :1446-1451
[28]   Neurotrophin regulation of cortical dendritic growth requires activity [J].
McAllister, AK ;
Katz, LC ;
Lo, DC .
NEURON, 1996, 17 (06) :1057-1064
[29]   ANTICONVULSANT AND ANTIEPILEPTOGENIC ACTIONS OF MK-801 IN THE KINDLING AND ELECTROSHOCK MODELS [J].
MCNAMARA, JO ;
RUSSELL, RD ;
RIGSBEE, L ;
BONHAUS, DW .
NEUROPHARMACOLOGY, 1988, 27 (06) :563-568
[30]  
MCNAMARA JO, 1987, NEUROTRANSMITTERS EP, P115